This is a non-event for ABT. Monitor the October 6, 2026 ESI protocol deadline and any subsequent discovery disputes, but this filing provides no actionable trading signal.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+20- T+0 · Sep 15 $102.03entry
- T+1 · 2mo ago +0.32%α +0.76% · $102.36
- T+5 · 8w ago +1.63%α −0.48% · $103.69
- T+20 · 5w ago +0.57%α −2.15% · $102.61
- T+44 · todayOpen
- T+60 · in 22d Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
This is a routine procedural order in a consumer class action against Abbott Diabetes Care and Abbott Laboratories regarding FreeStyle CGM products. The parties jointly stipulated to extend the deadline to submit a proposed ESI protocol from September 14, 2026 to October 6, 2026. The order contains no substantive rulings on liability, damages, or injunctive relief, it is a scheduling extension, the fourth such request, with no impact on any other case deadlines. For a $178B market cap company, this is immaterial housekeeping.
Key Facts
- Court granted a joint stipulation to extend the deadline for submitting a proposed ESI protocol from September 14, 2026 to October 6, 2026.
- This is the fourth stipulated extension of this deadline in the FreeStyle CGM consumer litigation.
- The order does not alter any other case deadlines or events.
- No substantive ruling on liability, damages, or injunctive relief was made.
Financial Impact
No financial impact, purely procedural scheduling order with no monetary exposure stated.
Risk Factors
- Ongoing consumer class action creates eventual settlement or adverse judgment tail risk, but this procedural step does not change that risk profile.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 court opinion.
| Document | Accession Number |
|---|---|
| COURT-RULING Data (Synthetic) | court-82d0c37cee-ABT |
Track record
38 reports on ABT
7 of 8 bullish or bearish reports moved the stock their way by T+20. Best: +17.16% at T+20 after the Jul 1, 2026 report. 8 of 9 went positive at some point.
Filters
- Nov 5, 202611d ago 144 Neutral 2/10 Entry $109.93 Now $107.45 −2.26% settles Dec 7
- Oct 27, 202620d ago ANALYST-DOWNGRADE Neutral 2/10 Entry $103.10 Now $107.45 +4.22% settles Nov 24
- Oct 27, 202621d ago Court Ruling Neutral 1/10 Entry $102.64 Now $107.45 +4.69% settles Nov 25
- Oct 21, 202626d ago Institutional Cluster Mixed 4/10 Entry $102.51 Now $107.45 +4.82% settles Nov 19
- Oct 21, 202626d ago 8-K Bullish 6/10 Entry $100.51 Now $107.45 +6.90% settles Nov 18
- Oct 21, 202626d ago 8-K Bearish 6/10 No price data
- Oct 21, 202626d ago Press Release Neutral 4/10 Entry $100.51 Now $107.45 +6.90% settles Nov 18
- Oct 20, 202628d ago Court Ruling Neutral 1/10 Entry $100.51 Now $107.45 +6.90% settles Nov 18
- Oct 16, 20264w ago Court Ruling Neutral 2/10 Entry $104.06 to $107.45 Now $107.45 +3.26% ▲ +3.26% +6.72% vs SPY
- Oct 15, 20264w ago Court Ruling Bullish 5/10 Entry $104.89 to $108.52 Now $107.45 +2.44% ▲ +3.46% +4.62% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time Court Ruling Intelligence
Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more, parsed and scored by AI.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers